SCHEMBL9534833

SCHEMBL9534833

O=c1c2c(Cl)cccc2nc2sccn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.47
PKM P14618 2/20 0.47
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TSHR P16473 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PARP1 P09874 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.39
MAPT P10636 2/20 0.38
DYRK1A Q13627 2/20 0.38
ELANE P08246 1/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9770762 0.82 CYP1A2 (0.43) CYP1A2SMN1; SMN2PKMRAB9ATSHR
SCHEMBL9535141 0.82 CYP1A2 (0.50) CYP1A2SMN1; SMN2PKMNPC1RAB9A
SCHEMBL9534383 0.82 TDP1 (0.50) CYP1A2SMN1; SMN2PKML3MBTL1ALDH1A1
SCHEMBL10696638 0.79 CYP1A2 (0.40) CYP1A2SMN1; SMN2PKML3MBTL1ALDH1A1
SCHEMBL9534033 0.79 PKM (0.50) CYP1A2SMN1; SMN2PKMTSHRL3MBTL1
SCHEMBL9534961 0.79 CYP1A2 (0.43) CYP1A2SMN1; SMN2PKMNPC1RAB9A
SCHEMBL9532712 0.79 CYP1A2 (0.53) CYP1A2SMN1; SMN2PKMNPC1RAB9A
SCHEMBL9534103 0.78 SMN1; SMN2 (0.41) CYP1A2SMN1; SMN2PKMNPC1RAB9A
SCHEMBL9532954 0.78 SMN1; SMN2 (0.41) CYP1A2SMN1; SMN2PKMNPC1RAB9A
SCHEMBL9534657 0.77 CYP1A2 (0.42) CYP1A2SMN1; SMN2PKMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0263523-B1 Process for the preparation of thiazolo [2,3-b] quinazolones BASF AG (DE) 1993-12-29 EP disclosed
EP-0263523-A2 Process for the preparation of thiazolo [2,3-b] quinazolones BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed